Biologic therapy in psoriasis patients with current or previous solid tumor malignancy: A systematic review

Published: 18 November 2024| Version 1 | DOI: 10.17632/k93hc5w5jt.1
Contributor:
Ryan Geng

Description

Psoriasis is a helper T cell 17-driven chronic inflammatory disease.​ Although targeted biologics revolutionized management, the utility and safety of biologics in psoriasis patients with current or previous solid tumor malignancy (PPM) remains uncertain.​​ This systematic review investigates evidence surrounding this indication.

Files

Categories

Dermatology

Licence